News for Cassava Sciences, Inc. (PX91.F)

SAVA stock is screaming for the top in the premarket hours after the company announced that it's moving forward with Pivotal trials.

AUSTIN, Texas, Feb. 12, 2021 -- Cassava Sciences, Inc. , a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the closing of its previously announced... | February 12, 2021

AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA) (the "Company" or "Cassava Sciences"), a clinical-stage biotechnology ...

AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the "Company" or "Cassava Sciences"), a clinical-stage biotechnology

AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company” or “Cassava Sciences”), a clinical-stage...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 ...

Cassava Sciences Inc. undefined said Wednesday it is planning a registered direct offering of $200 million of shares, priced at $49 each, or a discount over...

Cassava Sciences Inc (NASDAQ: SAVA) shares were trading solidly higher Monday on above-average volume in reaction to updates from the company on clinical ...

Shares of Cassava Sciences Inc. undefined rallied 18.5% in premarket trading on Monday after the company said it plans to start a double-blind, randomized,...

AUSTIN, Texas, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company developing product candidates ...

The stock fell 80% in the last five days, its worst weekly performance on record, to $63.77 in New York.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.29%

(Bloomberg) -- GameStop Corp. and AMC Entertainment Holdings Inc. rebounded after Robinhood Markets removed limits on buying the two stocks, which have been at the center of the battle between Reddit-empowered retail traders and short-sellers.Both shares rose Friday, with GameStop’s surge of as much as 78% triggering three volatility halts after whipsawing between gains and losses. It was up about 36% to $72.89 as of 10:34 a.m. in New York. AMC shares were up 4.2% after surging as much as 17%.Robinhood’s move, announced in an update on the trading platform’s support page, comes a day after it increased limits on purchases of the two stocks. Both have skyrocketed since late January as day traders who populate Reddit’s WallStreetBets forum sought to fend off short-sellers.GameStop’s volatile morning came amid a rush of volume over the first hour of trading. With about 40 million shares swapping hands, the rate of buying and selling at the start of the session was double what’s been seen over the past week.GameStop had plunged 84% so far this week through Thursday while AMC tumbled 47% as retail traders flocked to other corners of the stock market, such as small drug developers. Shares of the video game retailer have plummeted 84% since hitting a record intraday peak of $483 last week, reducing its market value by about $28.3 billion to $5.5 billion. The stock is still up 300% this year.Robinhood’s temporary restrictions on the Reddit group’s favorite stocks last week triggered an outcry among retail traders who said the brokerage had sided with hedge funds and institutional money. In order to shore up its capital amid the trading frenzy, the trading app operator has had to borrow or raise billions of dollars.Trading in other Reddit-favored names were mixed Friday morning with Naked Brand Group Ltd. and headphone maker Koss Corp. gaining after initial losses. Cannabis company Sundial Growers Inc., retailer Express Inc., and Ezgo Technologies Ltd. were among other “meme stocks” that erased gains to trade lower. Zomedica Corp. surged as much as 30% before trimming gains.Limits on trading and the quick declines for the likes of GameStop and Express led retail investors to snap up biotechnology companies like Cassava Sciences Inc. The small drug developer has boomed more than 700% this year to become the top stock in the Nasdaq Composite Index. Cassava fell as much as 24% on Friday.Robinhood’s RoleVlad Tenev, the chief executive officer of Robinhood, said in an opinion piece on USA Today this week that the firm built the trading app to serve the millions of people left behind by the U.S. financial system -- not hedge funds.The short-term curbs haven’t damaged the popularity of the no-fee app, founded in 2013. It was downloaded more than 600,000 times last Friday alone, according to research from SimilarWeb and JMP Securities LLC.Robinhood’s Role in the ‘Gamification’ of Investing: QuickTake(Updates with latest share price moves and additional details throughout.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

(Bloomberg) -- Biotech mania has overtaken internet chat rooms, pushing aside recent retail trading stars GameStop Corp. and Express Inc.Cassava Sciences Inc. nabbed the top spot as best microcap stock performer this year with an almost 680% rally.The small drug developer now has a market value of nearly $2 billion after briefly surpassing the $3 billion mark earlier this week. Its surge since the start of the year has displaced GameStop as the leader in the Russell Microcap Index. GameStop’s return had dwindled to about 184% through Thursday’s close, down from more than 1,000% at the end of last week.Trading in Cassava on Tuesday was frenzied with 76 million shares exchanging hands. Multiple trading halts were triggered after the Austin, Texas-based company released results from a small study of an experimental medicine in Alzheimer’s disease.One day later, Cassava was among the top seven most purchased stocks by retail investors, according to Eric Liu, the cofounder of Vanda Research. At the same time GameStop retail interest fell back to mid-January levels and Express saw investors flee.“Retail has basically just been rotating from one hot sector to the next,” Liu said. While retailers and silver funds sold off, pot stock Tilray Inc. and biotech Vaxart Inc. took the lead among the latest retail favorites, according to Vanda’s data.Pandemic reopening trades have gone out of favor for growth stocks which were later overtaken by electronic vehicles. Now touts on WallStreetBets are poised to take the lead.Meanwhile, even Cassava’s most bullish analyst was circumspect about the results from a small 100-person study.“Although encouraging, we interpret these observations with caution being from an non-controlled study,” Charles Duncan, an analyst with Cantor Fitzgerald wrote in a Feb. 2 research note.Results will have to be confirmed in a much larger placebo-controlled study, and the company plans to pursue a late-stage study in the latter half of this year. Duncan rates the company the equivalent of a buy and has a Wall Street high price target of $24. The stock gyrated on Thursday closing down 28% after gaining 34% intraday.Cassava was down 16% to $53.21 at 10:12 a.m.(Updates with Friday trading and year-to-date performance.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

The shares of GameStop Corp. (NYSE: GME) and AMC Entertainment Holdings Inc. (NYSE: AMC) are trading higher in the pre-market session at press time on ...

(RTTNews) - Today's Daily Dose brings you news about Johnson & Johnson seeking FDA nod for its single-shot COVID-19 vaccine candidate, T2 Biosyste...

GameStop Corp. capped another day of heavy losses, pushing its collapse past 80% this week as retail traders flocked to other corners of the stock market such as small drug developers. The video-game retailer tumbled 42% on Thursday to $53.50, erasing nearly $30 billion in market value. Trading…

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.80%

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 3) 9 ...